Categories Analysis, Leisure & Entertainment
Activision Blizzard Stock: Why ATVI is a good pick in COVID era
The company is all set to launch the new version of its flagship game franchise Call of Duty in the fourth quarter
There has been a steady increase in the consumption of online content ever since the coronavirus forced people to stay indoors. Activision Blizzard, Inc. (NASDAQ: ATVI), the maker of popular games like Candy Crush, is one of the beneficiaries of the COIVD-induced movement restriction.
The Call of Duty Saga
The Santa Monica, California-based game publisher is all set to launch a new version of its flagship franchise Call of Duty, tentatively in the fourth quarter. The yet-to-be-named game will be made available on old and new-generation consoles, to offer users a seamless gaming experience.
Read management/analysts’ comments on Activision’s Q2 earnings
Market watchers are bullish on the growth prospects of the stock and unanimously recommend investing in the company. It is widely expected that the shares would shrug off their current weakness very soon and return to the growth path — to gain as much as 44% in the next twelve months. In short, ATVI has what it takes to create handsome shareholder value.
Digital Power
Activision’s earnings mostly exceeded Wall Street’s estimates during the pandemic so far, which is a testament to its resilience to the crisis. In the June quarter, sales grew about 20% from last year to $2.3 billion, driven by the continued strength of the core Digital Online business that registered double-digit growth across all geographic segments.
From Activision Blizzard’s second-quarter earnings conference call:
“Our team continues to enhance the game building on learnings from player data and leveraging over 15 years of Call of Duty content to deliver increasingly compelling content and driving greater player investment over time. As we build on this momentum, we recently added new social game play to the title and have new mode, map, and seasonal events planned for the second half of the year.”
The buoyant demand conditions and new game launches should contribute to revenue growth going forward. However, there are concerns that the market reopening would once again change people’s content consumption habits, reversing a part of the current momentum.
Growing User Base
Of late, the company has been generating the lion’s share of its revenue from in-game content, rather than game sales, suggesting stronger player engagement. Call of Duty expanded its user count sharply in the recent past and downloads reached record highs, which in turn contributed positively to cash flow. Encouraged by its success, the management is planning to replicate the Call of Duty model in other games.
Earlier, rival game publisher Take-Two Interactive Software, Inc. (NASDAQ: TTWO) reported better-than-expected first-quarter numbers, despite a modest decline in revenues. The positive results failed to impress the market as the company’s future guidance fell short of expectations.
Executive Shake-up
Meanwhile, the head of Blizzard Entertainment Allen Brack made an unceremonious exit from Activision Blizzard this week, following allegations of improper behavior at workplace. He will be replaced by senior executives Jen Oneal and Mike Ybarra.
Top gaming stocks for your portfolio
The harassment scandal took the sheen off the impressive second-quarter performance and Activision’s stock dropped Tuesday evening. After climbing to a record high in February, the stock had pulled back and experienced fluctuation. The shares lost about 11% since the beginning of the year and often traded below their long-term average.
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on